The Lancet Gastroenterology & Hepatology in conversation with

Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis

The Lancet Gastroenterology & Hepatology

Rupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis.

Read the full article:
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS)

Continue this conversation on social!

Follow us today at...

https://bsky.app/profile/lancetgastrohep.bsky.social

https://www.linkedin.com/company/langastro/

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://youtube.com/thelancettv